Cenduit Selects SAP BusinessObjects to Revolutionize Clinical Trial Reporting & Analytics

WALLDORF, Germany, Dec. 9, 2009 /PRNewswire/ 

Cenduit, LLC, a joint venture of industry powerhouses Quintiles and Thermo Fisher Scientific, recently selected SAP BusinessObjects Enterprise solutions to enhance custom reporting and analytics capabilities within its Interactive Response Technology (IRT) solutions.

Cenduit's IRT solution is instrumental in collecting, analyzing and managing clinical trial data. Cenduit's clients -- pharmaceutical, clinical research and biotechnology organizations -- rely on IRT solutions to effectively manage randomization and drug supply management of their clinical studies. The SAP® BusinessObjects™ software includes visually compelling, ad-hoc reports and digital dashboards through which Cenduit takes the business efficiencies of its proven IRT solution to the next level.

"We carefully chose the SAP BusinessObjects Enterprise reporting and analytics solution since it is simply the best in class solution for analytics and reporting available today," said Dr. Jogin Desai, chief executive officer, Cenduit. "Real-time information on patient recruitment and drug supply management will enable our project managers to proactively advise clients and partners on business decisions to improve study productivity and dramatically reduce clinical trial costs."

Business intelligence gleaned from trends in programs over time will help clinical trial personnel devise meaningful strategies for running cost-efficient clinical trials. Together, Cenduit and SAP provide best-in-class clinical trial solutions that focus on transforming data-driven decision-making throughout the drug supply chain management and drug development process to achieve substantial study efficiencies and cost savings.

About Cenduit, LLC

Cenduit is a privately owned joint venture of Quintiles and Fisher Clinical Services, a division of Thermo Fisher Scientific.  Cenduit has successfully deployed IRT solutions in over 650 clinical studies.  Cenduit’s IRT solution is currently being used in Phase I through Phase IV clinical trials by over 16,000 sites in 78 countries, to enroll more than 220,000 subjects for over 30 indications.  There are currently 46 languages utilized in the Cenduit IRT platform, supporting all languages in the ISO country list.  Cenduit is dedicated to Quality, Partnership, Efficiency, and Exemplary Customer Service.  Cenduit has over 200 domain specialists consisting of project management, technical, validation, programming, and quality control/assurance global staff located in Research Triangle Park, North Carolina USA, Allentown, Pennsylvania USA, Horsham, London UK, Basel, Switzerland, and Bangalore, India.

About SAP BusinessObjects

SAP is the world’s leading provider of business software with more than 41,200 customers in more than 120 countries running SAP applications — from distinct solutions addressing the needs of small and midsize enterprises to suite offerings for global organizations.  A key component of SAP’s growth strategy is to significantly increase its revenues from new products including addressing the growing demands of business users. “BusinessObjects helps companies transform the way they work through the use of intelligent information,” said Bernard Liautaud, Chairman and Founder of BusinessObjects. “The combination of BusinessObjects and SAP means that we can truly amplify the reach of Business Intelligence – from the C-suite to Main Street.”

Headquartered in Paris, France BusinessObjects is widely recognized as the pioneer of the business intelligence (BI) software category. Today, BusinessObjects is the world’s leading BI software company with solutions spanning the information discovery and delivery, information management, analysis and performance management categories for more than 44,000 customers around the globe.

Media Contacts: 

Dorit Shackleton, SAP, +1 (604) 974-2444, .(JavaScript must be enabled to view this email address), PST
Amy Quarfot, Cenduit, LLC, +1 (919) 998-3870, .(JavaScript must be enabled to view this email address), EST